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Background: The homeobox transcription factor Engrailed2 (En2) has been studied extensively in
neurodevelopment, particularly in the midbrain/hindbrain region and cerebellum, where it exhibits dynamic
patterns of expression and regulates cell patterning and morphogenesis. Because of its roles in regulating cerebellar
development and evidence of cerebellar pathology in autism spectrum disorder (ASD), we previously examined an
ENGRAILED2 association and found evidence to support EN2 as a susceptibility gene, a finding replicated by several
other investigators. However, its functions at the cell biological level remain undefined. In the mouse, En2 gene is
expressed in granule neuron precursors (GNPs) just as they exit the cell cycle and begin to differentiate, raising the
possibility that En2 may modulate these developmental processes.
Methods: To define En2 functions, we examined proliferation, differentiation and signaling pathway activation in
En2 knockout (KO) and wild-type (WT) GNPs in response to a variety of extracellular growth factors and following
En2 cDNA overexpression in cell culture. In vivo analyses of cerebellar GNP proliferation as well as responses to
insulin-like growth factor-1 (IGF1) treatment were also conducted.
Results: Proliferation markers were increased in KO GNPs in vivo and in 24-h cultures, suggesting En2 normally
serves to promote cell cycle exit. Significantly, IGF1 stimulated greater DNA synthesis in KO than WT cells in culture,
a finding associated with markedly increased phospho-S6 kinase activation. Similarly, there was three-fold greater
DNA synthesis in the KO cerebellum in response to IGF1 in vivo. On the other hand, KO GNPs exhibited reduced
neurite outgrowth and differentiation. Conversely, En2 overexpression increased cell cycle exit and promoted
neuronal differentiation.
Conclusions: In aggregate, our observations suggest that the ASD-associated gene En2 promotes GNP cell cycle exit
and differentiation, and modulates IGF1 activity during postnatal cerebellar development. Thus, genetic/epigenetic
alterations of EN2 expression may impact proliferation, differentiation and IGF1 signaling as possible mechanisms that
may contribute to ASD pathogenesis.
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The homeobox transcription factor Engrailed2 (En2) has
been studied extensively in neurodevelopment, particu-
larly in the organization of the midbrain/hindbrain
region and the cerebellum, where it exhibits dynamic,
prenatal and postnatal expression patterns and complex
regional functions [1,2]. Because of its roles in regulating
cerebellar morphogenesis and Purkinje neuron develop-
ment, and evidence of cerebellar pathology in human
disease [3-6], we previously examined ENGRAILED2’s
association with human autism spectrum disorder (ASD)
and found evidence to support EN2 as an ASD suscepti-
bility gene. These results, initially observed in 167 fam-
ilies, were subsequently replicated in two additional data
sets (518 families; P = 0.00000035), and six other groups
have demonstrated EN2 association with ASD [7-12].
In the developing mouse brain, En2 restricts the fate
of progenitor cells to a midbrain/hindbrain lineage and
regulates cerebellar growth, patterning and connectivity.
For example, En2 deletion mutants exhibit hypoplastic
cerebella with reduced numbers of Purkinje neurons as
well as foliation defects and mistargeted spinocerebellar
afferents [13-17]. Interestingly, transgenic misexpression
of En2 that increases gene expression in postnatal
cerebellum also produced similar phenotypes, suggesting
that proper levels of En2 expression are required for
normal development [18-20]. The fetal expression of
En2 in the mouse follows a complex pattern, initially
expressed diffusely at the mid-hindbrain junction of
the brainstem, but becoming increasingly restricted to
the postnatal, developing cerebellum [1,21,22]. While the
major cerebellar output neurons, the Purkinje cells, are
generated prenatally, cerebellar expansion and its adult
morphology result from massive proliferation of the gran-
ule neuron precursors (GNP) located in the postnatal ex-
ternal germinal layer (EGL) covering the cerebellum
[13,16,18,23]. In the EGL, GNPs proliferate in the outer
portion, whereas postmitotic precursors start differenti-
ating in the inner layer. Significantly, En2 gene expres-
sion is increased in GNP as they exit the cell cycle
and begin to differentiate, raising the possibility that
En2 may participate in these developmental processes
[14,15,24]. Because En2 mutants have decreased numbers
of Purkinje neurons that provide mitogenic growth factors
for GNP proliferation, cerebellar hypoplasia has been con-
sidered a consequence of their deficiency. However, as an
alternative hypothesis, En2 expression in GNPs themselves
may play a cell-autonomous role in regulating prolifera-
tion and differentiation. We now explore the function of
En2 during GNP development by comparing wild-type
(WT) and knockout (KO) GNPs both in vivo and in cul-
ture, as well as by using En2 overexpression constructs.
ASD is a highly heritable genetic disorder [25,26], with
interactions between multiple susceptibility genes as wellas environmental factors manifesting as diverse clinical
presentations [27]. How individual susceptibility genes
such as EN2 contribute to disease risk (individually and
in aggregate with other genes) remains to be elucidated.
Cerebellar granule neurons are the largest population of
neurons in the brain, and the only major population to
continue neurogenesis postnatally, compared to more
limited adult neurogenesis in the forebrain [23,28,29]. In
humans, this process extends through infancy, the
period when ASD symptoms first manifest. Significantly,
multiple lines of evidence suggest that cerebellar
dysfunction contributes to ASD symptomology [6].
Neuropathological studies demonstrate Purkinje neuron
deficits in the majority of brains examined to date,
whereas structural MRIs indicate that subsets of individ-
uals have hypoplastic cerebellar vermis and others have
enlarged cerebellar hemispheres [5,30,31]. Functional
brain imaging studies suggest that cerebellar dysfunction
contributes to the motor, cognitive and language deficits
observed in ASD [4,32-35]. Thus, a disruption of early
postnatal cerebellar development could potentially con-
tribute to ASD pathogenesis. From this perspective, by
defining the role of En2 in postnatal GNP neurogenesis,
we may identify cellular pathways by which variations in
the levels of En2 expression may contribute to disordered
cerebellar development, potentially providing insight into
ASD pathophysiology. We now define En2 function in
postnatal cerebellar development, specifically the period
when GNPs transition from proliferation to differentiation
concomitantly with their expression of En2 [15,36]. We
demonstrate that without En2, GNPs favor proliferation
over differentiation, whereas En2 overexpression promotes
GNP cell cycle exit and differentiation. Furthermore, we




Time-mated Sprague-Dawley rats were obtained from
Hilltop Lab Animals, Inc. (Scottdale, PA) and main-
tained on a 12:12 light:dark cycle with ad libitum Purina
rat chow and water. Rats were killed by CO2 gas
asphyxiation as approved by RWJMS IACUC. Male
and female breeding pairs of C57BL6 J/129S2SV PAS
mice heterozygous (HT) for a functional deletion of
En2 [13] were obtained from The Jackson Laboratory
(no. 002657; Bar Harbor, ME) and maintained. An
En2 mutant colony was propagated by HT × HT inter-
crosses, and genotyping of the progeny was performed
as described (jaxmice.jax.org). The mice were initially
maintained as heterozygous matings, but, to generate
adequate numbers of pups of known genotype for GNP
cultures, WT × WT and KO × KO mating pairs were
established.
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the Robert Wood Johnson Medical School Institutional
Animal Care and Use Committee. Animals were man-
aged by Robert Wood Johnson Animal Facility, and
maintenance, husbandry, transportation, housing and
use were in compliance with the Laboratory Animal
Welfare Act (PL 89–544; PL-91-579) and National Insti-
tutes of Health guidelines (Manual Chapter 4206).Recombinant DNA
A full-length En2 cDNA was cloned from C57BL6
J/129S2SV PAS adult mouse cerebellum as described
previously [7]. To identify transfected cells, the En2 cod-
ing sequence was moved to the pCMS-EGFP expression
vector (Clontech, Mountain View, CA) by EcoRI diges-
tion and ligation. Orientation of positive clones was de-
termined by Kpn1 digestion.Mouse and rat cerebellar granule neuron precursor
(GNP) culture
Postnatal day (P)7 rat and WT or KO mice were decapi-
tated and cerebellar GNPs isolated as described previously
[37,38]. Briefly, 3–6 cleaned cerebella were incubated 3
min in trypsin-DNase solution (1% trypsin, 0.1% DNase,
Worthington, Lakewood, NJ) and dissociated in DNase
solution (0.05% in DMEM) by trituration. After pelleting,
cells were filtered (30-um nylon mesh; Tekton, Tarrytown,
NY), resuspended and centrifuged at 3,200 rpm on a
Percoll (Sigma, St. Louis, MO) 35:60% step gradient
[39,40]. Cells at the 35:60% interface were collected and
washed in phosphate buffer, then plated onto a poly-
D-lysine (0.1 mg/ml)-coated 60-mm culture dish in de-
fined medium (DM) composed of a 1:1 mixture of F12
and DMEM, 10 ng/ml insulin, 100 ug/ml transferrin, 10
mg/ml bovine serum albumin, 100 uM putrescine, 20 nM
progesterone, 30 nM selenium, 6 mg/ml glucose, 50 U/ml
penicillin and 50 ug/ml streptomycin. Unless stated other-
wise, components were obtained from Sigma. After 1 h of
preplating to remove adherent flat cells (<2% of cells),
small round (granule) cells were dislodged by gentle
pipetting and plated at ~104-5 × 104/cm2 on poly-
D-lysine-coated 35-mm Nunc (Thermo Fischer Scientific,
Rochester, NY) culture dishes or 24 multiwells. Cultures were
maintained in a humidified 5% CO2/air incubator at 37°C.
For thymidine incorporation studies, cells were cul-
tured in DM alone or with additional factors: high-dose
insulin (10 ug/ml), 1–100 ng/ml IGF1 (Cell Sciences,
Canton, MA), 0.1-3 ug/ml Shh-N (N-terminal fragment,
R&D Systems, Minneapolis, MN), 10-12-10-7 M PACAP1-
38 in 0.01 N acetic acid vehicle (American Peptide,
Sunnyvale, CA), 10 ng/ml FGF2 (gift of Scios, Mountain
View, CA), 10–30 ng/ml BDNF (PeproTech, Rocky Hill,
NJ), 100 ng/ml EGF, 100–300 ng/ml VEGF or 10-30%conditioned media (CM) harvested from control- or
Wnt3a-transfected fibroblasts.
For differentiation, cells were assessed live 24 h post
plating by phase microscopy or were fixed in 4% cold
paraformaldehyde and processed for immunocytochem-
istry, then assessed by phase or fluorescence microscopy.
To assess neurites, cells bearing processes greater than
two-cell soma diameters were assessed at 24 h in the
live state, as reported previously [41], or following fix-
ation and immunostaining against beta-III-tubulin as de-
scribed below. Cells in two or three 1-cm rows (1.0-1.5%
of the culture dish area) bearing neurites >2 cell soma
were counted blind in two to four dishes per group, and
experiments were performed three or more times.
Assessment of DNA synthesis
Incorporation of 3H-deoxythymidine (3H-dT, 1uCi/ml)
was used to assess DNA synthesis, as described previ-
ously [38,42,43]. Cells were incubated with 3H-dT
during the final 4 h of culture. DNA that had incorpo-
rated 3H-dT was collected onto glass fiber filters by a
semiautomatic cell harvester (Skatron), and the radioli-
gand was assessed by scintillation spectroscopy. To
visualize cells synthesizing DNA, GNPs were exposed to
the S-phase marker bromodeoxyuridine (BrdU) (10 uM,
Sigma) during the final 4 h of incubation. After fixation,
cells were either exposed to 2 N HCl (30 min) or pre-
treated with PBS/0.3% Triton X-100 and then DNaseI
(500 U/ml, Worthington) [44] and subsequently proc-
essed for BrdU immunocytochemistry using monoclonal
anti-BrdU (1:200; Dako, Carpinteria, CA) and visualized
using a Vectastain avidin-biotin complex kit and Vector
SG peroxidase substrate with a 3,3′-diaminobenzidine
(DAB) chromogen (Vector Laboratories, Burlingame,
CA) as previously described [45]. The labeling index, de-
fined as the proportion of total cells incorporating BrdU
into the nucleus, was determined by scoring the cells in
five randomly selected, non-overlapping fields in each of
the two to four dishes per group per experiment.
cDNA transfection of GNPs
Rat and mouse GNPs were plated 2-4 × 105cells/cm2
onto 12- or 25-mm glass coverslips (VWR International,
West Chester, PA) pretreated with 2 N HCl for 30 min,
rinsed in dH2O for 30 min, serially washed in 90%
and 100% ethanol and fire-polished, then coated with
poly-D-lysine (0.1 mg/ml) and fibronectin (1 ug/cm2,
Sigma). Transfection media consisted of Neurobasal
supplemented with 2% B27 (Invitrogen) containing glu-
tamine (Gln, 2 mM), penicillin (50 U/ml), streptomycin
(50 mg/ml), BSA (1 mg/ml), and either FGF2 (10 ng/ml)
for rat GNPs or Shh (3 ug/ml) and BDNF (30 ng/ml) for
mouse GNPs. For both species, 1 h after plating, cells
were gently washed with Neurobasal supplemented with
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media containing Neurobasal supplemented with 2% B27
and 10 ug/ml Gln, and either Lipofectamine Plus or
Lipofectamine LTX Plus (Invitrogen) and 1 ug/ml pCMS-
EGFP (GFP) or 1.2 ug/ml pCMS-EGFP-En2 (En2). After
5 h, transfection reaction media were replaced with
species-specific transfection media (as above) and cells
were incubated an additional 24 h, then fixed in cold 4%
paraformaldehyde. Successful transfection was determined
by GFP autofluorescence, assessed by fluorescence micros-
copy prior to fixation or other procedures.
Immunocytochemistry
Following fixation, cells were incubated 1 h at room
temperature (RT) in 33% goat, rabbit or horse serum,
then 1 h at RT or overnight at 4°C in one of the follow-
ing primary antibodies diluted in PBS/0.3% Triton X-
100, 2% serum and 0.05% NaN3: TuJ1, monoclonal
mouse anti-beta-III-tubulin (1:9,000, Covance Research,
Inc., Berkeley, CA), monoclonal mouse anti-PCNA (F2)
(1:1,000, Santa Cruz, Inc., Santa Cruz, CA) or polyclonal
chicken anti-GFP (1:5,000, Chemicon). Cells were then
incubated 1 h with biotinylated horse anti-mouse sec-
ondary antibody and visualized with DAB chromogen or,
alternatively, Alexafluor 488 (green) or 594 (red) fluores-
cent goat anti-mouse, goat anti-rabbit, rabbit anti-
chicken, rabbit anti-mouse or rabbit anti-goat secondary
antibody (1:1,000, Chemicon), followed by 5 min incuba-
tion with 4′,6-diamidino-2-phenylindole dihydrochloride
(DAPI, 1 ug/ml, Sigma). Glass coverslips were inverted
and mounted onto glass slides with Fluoromount-G
(EMS, Hatfield, PA) and assessed by fluorescence mi-
croscopy. Cells were counted blind from two randomly
selected fields within each of ten predetermined regions
covering greater than 80% of the coverslip, from 2–4
coverslips per group per experiment. Images were ac-
quired at 400× with and without background subtraction
via an Apotome filter using Axiovision 4.5 software
(Carl Zeiss Microimaging, Inc., Thornwood, NY).
Protein collection and western blot analysis
Isolated P7 KO and WT GNPs (2.5 × 106 cells/ml) were
incubated in 4 ml DM on poly-D-lysine-coated (0.01
mg/ml) 60-mm dishes. After 4 h incubation, 10 ng/ml
IGF1 was administered, followed by 15 min to 8 h incu-
bation, then cells were washed with PBS, lysed by 70 ul
lysis buffer containing 20 mM HEPES-KOH, pH 7.5,
5 mM KCl, 0.5 mM MgCl2 with 0.5 mM dithiothretiol
(DTT), 2 mM phenylmethylsulfonylfluoride (PMSF),
1 mM leupeptin and 3.5 mg/ml aprotinin, and collected
by scraping with rubber policeman. Samples were stored
at −80°C. For blotting, defrosted samples were lysed by
sonication and centrifuged, and the supernatant was
normalized to 0.1 M NaCl. Protein concentrations weredetermined by Bio-Rad protein assay (Bio Rad Labora-
tories, Inc., Hercules, CA), and bovine serum albumin
(BSA) dilutions served as standard curve. Protein ex-
tracts (50 ug per lane) were analyzed by 12% SDS-PAGE
and electrically transferred to a polyvinylidenediflouride
(PVDF) membrane. The membrane was blocked with
5% milk or 5% BSA and incubated with primary anti-
body against phospho- or total Akt, phospho- or total
ERK1/2, phospho- or total GSK3beta, phospho- or total
S6 kinase (1:1,000, Cell Signaling Technology, Danvers,
MA) or total actin (1:2500, Chemicon), followed by
monoclonal anti-mouse or polyclonal anti-rabbit horse-
radish peroxidase-conjugated secondary antibody, and
visualized with an enhanced chemiluminescence system
(Pierce, Rockford, IL), as previously reported [44,46].
In vivo IGF1 administration and cerebellar 3H-dT
incorporation
Groups of 3–5 P7 KO and WT pups were injected with
PBS and 0.01 N HCl vehicle or IGF1 (10 ug/g, Cell
Sciences) subcutaneously (sc) at time zero, followed at
6 h by 3H-dT (5 uCi/g, sc), and were killed at 8 h. Cere-
bella were cleaned of meninges, removed from the
brainstem, weighed in pre-tared microcentrifuge tubes
and homogenized in dH2O (volume = mass × 5). An
aliquot was removed for determination of total isotope
uptake into the tissue. In an equal aliquot, DNA was
precipitated with 10% trichloroacetic acid, sedimented
by centrifugation, and washed by resuspension and rese-
dimentation. The final pellet was dissolved and counted
along with the original aliquot in a scintillation spectro-
photometer. 3H-dT incorporation was defined as the
fraction of total radionuclide taken up by the whole
cerebellum that was present in the precipitated DNA
and was reported as percent incorporation [47,48].
In vivo BrdU immunohistochemistry
Two groups of three P7 KO and WT mice were injected
sc with BrdU (50 ug/g) and killed at 2 h. Whole brains
were removed and drop-fixed in fresh, cold 4% parafor-
maldehyde. Brains were serially dehydrated in 50, 60, 70,
80, 95 and 100% ethanol, 100% butanol and 100% xylene
under vacuum and embedded in paraffin wax. Brains
were then serially sectioned at 5 μm parasagittally,
and sections were mounted on glass slides, with 5–6
sections/slide collected and numbered consecutively.
Every fifth slide from WT and every fourth from KO
(due to the smaller cerebellar size) plus two slides
from either side of the central-most slide representing
the central vermis were deparaffinized and rehydrated
for anti-BrdU immunohistochemical processing. BrdU
incorporated in DNA was detected by monoclonal anti-
body (Becton-Dickinson), amplified by biotinylated sec-
ondary antibody (Vectastain ABC kits), visualized by
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terstained with basic fuchsin. BrdU immunoreactive
GNPs in the dorsal outer external germinal layer of lob-
ules IV and VIII were counted by camera-lucida micros-
copy, and the BrdU labeling index quantified as the
number of BrdU-positive cells/total cells × 100%. Four
to eight sections from the hemispheres and four to eight
sections from the vermis were counted for each pup
[37,48].
Statistical analyses
Data are expressed as mean ± SEM. Statistical compari-
sons were made by unpaired two-tailed Student’s t test or
two-way ANOVA using Excel (Microsoft) or Vassarstats
Website for Statistical Computation (www.vassarstats.net),
respectively.
Results
Proliferation is enhanced in vivo in the absence of En2
Cerebellar GNPs increase expression of En2 postnatally
in the inner EGL, concurrent with their cell cycle exit
and early differentiation; therefore, En2 may be an
important regulator of these processes. Using thymidine
analog bromodeoxyuridine (BrdU) to label cells in
S-phase, as previously published [48], we defined the
labeling index [BrdU LI; (BrdU+/total cells) × 100%] of
GNPs on postnatal day 7 (P7) of En2 KO and WT cere-
bellum (Figure 1A,B). BrdU-labeled GNPs were localized
normally in the outer EGL in both genotypes. The BrdU
LI was increased by 15% in En2 KO compared to the
WT (Figure 1C), suggesting En2 may regulate precursor
proliferation. Furthermore, genotype-dependent differ-
ences were even greater when proliferation was assessed
specifically in the centrally localized vermis, a region
that may express higher En2 levels [15,24]: the BrdU LI
was 23% in the WT, whereas it was increased to 30% in
the KO (Figure 1D). These results are consistent with a
model in which En2 normally suppresses S phase entry
of GNP in the EGL.
Differences in proliferation between En2 KO and WT GNPs
defined in vivo are preserved in culture
Differences in GNP proliferation in vivo may reflect the
effects of distinct environmental signals such as growth
factors derived from Purkinje neurons, which are re-
duced in the mutants, or alternatively, action of cell
autonomous signals, such as En2 expression [49]. Previ-
ously, we reported that in the absence of mitogens, spe-
cifically Shh, mouse GNPs in culture rapidly exit the cell
cycle [38]. Therefore, WT and KO GNPs were isolated
from the cerebellum and cultured at low density in de-
fined media without growth factors, and DNA synthesis
was assessed at 24 h by BrdU immunocytochemistry.
The proportion of GNPs in mitotic S-phase was two-fold higher in En2 KO cells (Figure 1E,F). Further, there
were similar numbers of live KO and WT GNPs counted
at 24 h (WT = 143 ± 10.4; KO = 120 ± 9.8, total cells/
five fields ± SEM; N = 5-6 per genotype; p = 0.14). These
in vitro results recapitulate the in vivo finding that En2
KO GNPs fail to exit the cell cycle at the same rates as
WT GNPs, an effect not likely due to changes in sur-
vival. These data also suggest that En2 participates in
cell-autonomous regulation of the GNP cell cycle, inde-
pendent of extracellular growth factors in the EGL.
However, this raises the question, does En2 also function
to modulate the effects of extracellular signals on cell
cycle regulation?
IGF1 stimulates enhanced proliferation in the absence of
En2 in culture and in vivo
Growth factors secreted by underlying Purkinje cells
have been well characterized as regulators of GNP pro-
liferation, differentiation and survival [49-52]; therefore,
abnormal GNP responses to growth factor signaling in
the absence of En2 expression may contribute to the KO
phenotype. To address this issue, we isolated En2 KO
and WT GNPs and compared proliferation, differenti-
ation and survival in culture without and with develop-
mentally relevant extracellular growth factors.
Mitogenic growth factors, those that promote G1/S-
phase transition, were added to defined media, and
DNA synthesis in KO and WT GNPs was assessed
by measuring 3H-deoxythymidine (3H-dT) incorpor-
ation. Sonic hedgehog (Shh), arguably the most well-
recognized mitogen in postnatal cerebellar development
[38,50,53-55], elicited identical increases in DNA synthe-
sis in both genotypes (Figure 2A). However, insulin-like
growth factor 1 (IGF1) and high-dose insulin, known
to act through the IGFI receptor [56], elicited two-
fold greater increases in DNA synthesis of KO GNPs
(Figure 2A). This differential genotype response was ap-
parent at physiologic concentrations of IGF1 and above
(Figure 2B). Since the dose-response profiles to IGF1
were similar between genotypes, the differential mito-
genic responses were not a function of the specific dose
employed, and the receptor-ligand binding kinetics are
apparently unchanged. Furthermore, Shh and IGF1
together increased DNA synthesis synergistically; how-
ever, the differential genotype-specific responses per-
sisted (Figure 2A). This suggests IGF1 may specifically
stimulate enhanced proliferation in the absence of En2.
To further explore the specificity of IGF1 effects, anti-
mitogenic stimuli, fibroblast growth factor-2 (FGF2) and
pituitary adenylate cyclase activating peptide (PACAP),
which block cell cycle progression in mouse GNPs [38],
were added to defined media, and DNA synthesis was
assessed (Figure 2C). FGF2 treatment reduced WT GNP
incorporation by 50%, whereas PACAP elicited a 25%
Figure 1 GNP proliferation in the cerebellum in vivo and in vitro. P7 WT and KO mice were injected with BrdU and killed 2 h later to
perform BrdU LI analysis in the EGL. (A) Low magnification (4×) images of 5-μm sagittal sections from WT and KO cerebellar vermis are shown.
As previously described [14,16], the KO cerebellum exhibits an overall smaller size. Arrows point to lobule IV. (B) At higher magnification, representative
vermis sections show the middle top portion of the folium of lobule IV. Overall tissue cytoarchitecture appeared similar, and BrdU labeled GNPs were
localized normally in both genotypes. Arrows denote proliferating GNPs in the outer EGL immunostained for S-phase marker BrdU; arrowheads denote
post-mitotic GNPs in the inner EGL. Insets show cells in the EGL. Bar = 50 μm; inset bar = 10 μm. (C) When assessed across the entire extent of the
cerebellum, the BrdU LI was moderately increased in the KO. (D) There was a greater increase in the KO LI when assessed within the cerebellar vermis.
N = 4-5 animals per genotype; 8–14 sections were counted per entire cerebellum; 4–6 sections were counted per vermis region. (E) Twenty-four-hour
cultures of WT and KO GNPs in control media are shown after fixation and BrdU immunocytochemisty. Upper panels show isolated GNPs under phase
microscopy, whereas lower panels reveal brightfield images. Arrows point to cells in phase that exhibit BrdU immunostaining in lower panels. Bar = 10
μm. (F) The GNP BrdU LI in vitro was two-fold greater in the KO compared to WT cells. For each experiment, GNPs were isolated from groups of 4–6
mice per genotype. N = 3 culture dishes per genotype per experiment, and three experiments were performed. EGL: External germinal layer; ML:
molecular Layer; PCL: Purkinje cell layer; IGL: inner granule layer. t-test: *p ≤ 0.05; **p ≤ 0.01.
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incorporation by 65%; virtually identical changes in
DNA synthesis were observed in KO GNPs. Moreover,
these anti-mitogenic signals attenuated IGF1-stimulated
increases in DNA synthesis in both genotypes. Nonethe-
less, IGF1 stimulated greater DNA synthesis in KO
GNPs even in the presence of these anti-mitogenic stim-
uli (Figure 2C). No other growth factors we tested
elicited differential genotype-specific responses in DNA
synthesis, including epidermal growth factor (EGF),
brain-derived neurotrophic factor (BDNF) and vascular
endothelial growth factor (VEGF), nor did Wnt-3a-conditioned media (data not shown). These data suggest
IGF1 signaling may be differentially regulated in the ab-
sence of En2 in cultured GNPs.
To determine whether IGF1 signaling is differentially
regulated by the absence of En2 in vivo, we administered
a single subcutaneous injection of IGF1 (10ug/gbw) to
P7 KO and WT mice and measured total cerebellar
tissue DNA synthesis using radiolabeled 3H-dT thymi-
dine. As previously described for effects of peripherally
injected bFGF on neonatal cerebellum [48], changes in
the magnitude of 3H-dT thymidine incorporation into
whole cerebellar homogenates (see [37], Figure one)
Figure 2 IGF1 stimulates greater DNA synthesis in En2 KO GNPs in culture and in vivo. (A) Mitogenic stimulation of KO and WT GNPs was
measured in 24 h cultures using 3H-dT incorporation. IGF1 (10 ng/ml) and high-dose insulin (10 μg/ml) differentially increased KO DNA synthesis
compared to WT, while Shh (3 μg/ml) elicited similar increases in both genotypes. Co-administration of IGF1 and Shh synergistically increased
DNA synthesis, though differential genotype responses to IGF1 remained. Data presented as percent control 3H-dT incorporation ± SEM; control:
350–550 cpm/well; growth factors: 800–2,200 cpm/well; 4–6 mice/genotype/experiment; 3–6 wells/treatment/experiment, derived from three
experiments. (B) IGF1 elicited differential genotype responses at doses above 1 ng/ml (Note: IGF1 elicited 3-4-fold increased KO DNA synthesis
in Figure 2A-B; WT responses were less consistent across experiments.) N = 6-9 wells/group, from 3 experiments. (C) Anti-mitogens reduced
DNA synthesis similarly across genotypes. FGF2 (10 ng/ml) and PACAP (10 nM) attenuated, but did not abolish, differential genotype responses
to IGF1. N = 6-9 wells/group from three experiments. (D) In vivo, IGF1 (10μg/gbw) also differentially increased cerebellar 3H-dT incorporation
(see Methods). 3H-dT incorporation after saline injection was not different between genotypes (WT = 73% + 1.6; KO = 66% + 3.5; p = 0.08). IGF1
significantly increased DNA synthesis over saline injection in both genotypes, however WT DNA synthesis increased 9.7% while KO DNA
synthesis increased 28%. Two-way ANOVA yielded significant genotype × IGF1 interaction. KO: N = 9 saline, N = 6 IGF1; WT: N = 12 saline, N = 6
IGF1; N = 6 experiments, a minimum of one pup per genotype was injected with saline and IGF1 in each experiment. Con: Control; F: FGF2;
P: PACAP: t-test *, compared between genotypes, p < 0.05; **p < 0.01; ***p < 0.001; t-test #, compared to genotype control, p < 0.05; ##p < 0.01;
###p < 0.001; %, compared within genotype, p < 0.05; $: two-way ANOVA, IGF1 F(1,29) = 28.5, p < 0.0001, genotype F(1,29) = 0.11, p = 0.74,
genotype × IGF1 interaction F(1,29) = 4.88, p = 0.035.
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lated GNPs (see [37], Figure four), supporting the value
of this approach. With regard to IGF1, previous studies
indicate that peripherally administered growth factor
actively passes the blood-brain-barrier via a saturable
transport mechanism and penetrates the brain paren-
chyma [41,57]. Preliminary studies conducted at 4, 8 and
12 h post-IGF1 injection, with a subcutaneous 3H-dT
(5uCi/g) injection 2 h prior to sacrifice, indicated the
greatest increase in DNA synthesis was observed at 8 h.
As we detected in culture, IGF1 significantly increased
total cerebellar DNA synthesis in both genotypes in vivo.
However, in the absence of En2, IGF1 elicited a far
greater increase in cerebellar DNA synthesis, increasing
3H-dT incorporation by 28% over saline injection in the
KO, whereas the increase was only 9.7% in the WT(Figure 2D). These data recapitulate in vivo that IGF1-
induced mitogenesis is differentially regulated in the ab-
sence of En2 and suggest En2 negatively regulates IGF1
signaling during postnatal cerebellar development.
Differentiation is diminished in the absence of En2
Postnatal En2 expression begins in postmitotic GNPs in
the inner EGL at, or just before, the start of differenti-
ation and migration [15,24], suggesting this gene may
regulate these processes. However, En2 KO mice develop
a mature, albeit smaller, IGL than the WT, suggesting
En2 may not be required for these processes but rather
may modulate them. To address GNP differentiation in
the absence of En2, KO and WT cells were cultured in
defined media for 24 h without and with growth factors,
and differentiation was assessed by quantifying neurite-
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media lacking growth factors, an identical percentage of
WT and KO GNPs extended neurites (WT = 16.5% ±
1.88; KO = 16.8% ± 0.74; percent bearing neurites ± SEM;
p = 0.86). When cultured with well-characterized neurito-
genic factors PACAP or IGF1 [51,52], WT cells exhibited
increased neurite outgrowth of 30% and 56%, respectively,
over that occurring in defined media alone. However, En2
KO GNPs failed to respond to PACAP, whereas IGF1 only
increased KO neurite outgrowth by 23%, a 59% reduction
(p ≤ 0.05) in IGF1-stimulated outgrowth compared to WT
levels (Figure 3B). Thus, in the absence of En2, GNPs
exhibit reduced growth factor-induced neurite outgrowth,
suggesting that En2 expression normally enhances differ-
entiation. Interestingly, simultaneous administration of
IGF1 and PACAP together “rescued” the KO GNP differ-
entiation deficit, increasing neurite outgrowth to WT
GNP levels (Figure 3B). These results may suggest there
are convergent signaling pathways downstream of PACAPFigure 3 En2 KO GNPs exhibit normal survival but diminished respon
GNPs were cultured in defined media without and with PACAP (10 nM), IGF
assessed under phase microscopy. (A) KO and WT GNP morphology was q
neurite-bearing cells differed, as quantified in B-C. Arrows denote neurites ex
without neurites >2 cell somas. (B) PACAP and IGF1 each induced fewer ne
IGF1 and PACAP stimulated KO GNP neuritogenesis equivalent to WT. Fo
genotype, derived from three experiments, yielding N = 6-9 dishes/gro
differentiation deficits observed in the absence of En2. FGF2 reduced n
neuritogenesis in WT cells only. In combined factor treatment, WT ce
displayed outgrowth inhibition similar to FGF2 treatment alone. These d
different pathways in GNPs, and the absence of En2 reduces IGF1 neuri
similar in 24-h culture in WT and KO GNPs in response to trophic facto
suggesting differences in DNA synthesis and neuritogenesis are unlikely to re
t-test *, compared between genotypes, p ≤ 0.05; t-test #, compared to genoty
genotype, p ≤ 0.0001.and IGF1 that together can promote GNP differentiation
even in the absence of En2.
However, there may be an alternative model for the
ability of PACAP plus IGF1 to overcome the neurite
outgrowth deficiency observed in KO GNPs. Specifically,
the anti-mitogenic effect of PACAP on both WT and
KO GNPs, as above (Figure 2C), may allow cells to
differentiate that would have otherwise continued to
proliferate. Thus, any anti-mitogenic signal would be ex-
pected to promote IGF1-induced neuritogenesis. To ad-
dress this issue, KO and WT GNPs were cultured with
FGF2, another anti-mitogenic signal, and effects of IGF1
were examined. FGF2, a strong anti-mitogenic signal in
both WT and KO GNPs (Figure 2C), elicited reductions
in neurite outgrowth in both genotypes, suggesting it
is not a pro-differentiation signal either (Figure 3C).
FGF2 significantly attenuated IGF1-induced neurite out-
growth by more than 30% in both genotypes (Figure 3C).
Thus, FGF2 represents both an anti-mitogenic and anti-se to neuritogenic signals compared to WT GNPs. KO and WT
1 (10 ng/ml) or both, and the percent of living, neurite-bearing cells was
ualitatively similar in response to PACAP and IGF1, though numbers of
tending many cell bodies from neuronal somas. Arrowheads identify cells
urite-bearing KO GNPs compared to WT GNPs. However, in combination
r each group, 2–3 dishes were assessed in each experiment for each
up/genotype. (C) Anti-mitogenic growth factors failed to overcome
eurite outgrowth in both genotypes, whereas IGF1 again stimulated
lls exhibited outgrowth equivalent to control media, but KO cells
ata suggest cell cycle exit and differentiation are mediated through
togenic effects. N = 6-14 dishes/group/genotype. (D) Cell survival is
rs (compared to counts at 2 h; 200–400 cells counted/dish at 24 h),
flect differences in survival or death. N = 6-11 dishes/group/genotype.
pe control, p ≤ 0.05; ## p ≤ 0.01; ### p ≤ 0.001; t-test %, compared within
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WT GNPs. These findings are consistent with at least
one report suggesting FGF2 inhibits neurite outgrowth
in cerebellar GNPs [59]. Further, these data suggest KO
GNP deficits in neurite outgrowth are not due to failed
cell cycle exit, but rather a specific failure or delay in dif-
ferentiation in the absence of En2.
In addition to regulating the cell cycle and differenti-
ation, both PACAP and IGF1 exert trophic support for
developing GNPs in the EGL [38,52]. Therefore, differ-
ences observed in DNA synthesis and neurite outgrowth
between WT and En2 KO GNPs could reflect differences
in survival. To examine survival, cells were plated at low
density (10,000 cells/cm2) to limit cell-cell contact and
counted at 24 h in defined media without and with
PACAP, IGF1, or PACAP and IGF1 together. Initial
counts were taken at 2 h post plating to ensure equal
numbers of cells were aliquoted and attached between
genotypes. As reported previously, both PACAP and
IGF1 increased the number of WT cells, and they exhib-
ited a trend toward additivity when co-administered
(Figure 3D). Significantly, En2 KO cells responded iden-
tically to WT GNPs, exhibiting similar increases in cell
numbers when incubated with PACAP, IGF1 and com-
bined factors (Figure 3D). Thus, the absence of En2 does
not appear to be deleterious to GNP survival or to alter
the trophic responses to growth factors. Further, these
data suggest differences in DNA synthesis and neurite
outgrowth observed between KO and WT GNPs are due
to differentially regulated mechanisms underlying mi-
tosis and differentiation, and not differences in cell sur-
vival or cell death.
IGF1 signaling is altered in the absence of En2
As shown above, IGF1 is a pleiotropic signal in the
developing cerebellum, regulating proliferation, neurite
outgrowth and survival via its tyrosine-kinase receptor,
the IGF1 receptor (IGF1R), which is activated through
receptor autophosphorylation of tyrosine residues [60].
Activated IGF1R in turn binds and activates one of
several phosphorylation cascades engaging different sig-
nal transduction pathways, with phosphotidylinositol-3-
kinase (PI3K) being one of the most commonly activated
in cerebellar GNPs [61-63]. PI3K can induce activation
of phosphokinase B/Akt (Akt), leading to inhibition of
glycogen synthase-kinase-3-beta (GSK3beta), and can
promote proliferation and survival [64,65]. Alternatively,
IGF1 signaling can activate ras/raf-MEK, which activates
the mitogen-activated protein kinase (MAPK)/extracel-
lular signal-regulated protein kinase 1 and 2 (ERK1/2),
leading to survival and differentiation [66]. To determine
which cascades may underlie genotype-specific effects
of IGF1, protein levels and the activation ratios of
phospho-Akt/Akt (P-Akt) and phopho-ERK1/2/ERK1/2(P-ERK) were measured by Western blot. Initial compar-
isons were made between untreated, whole cerebellar
lysates from P7 KO and WT mouse pups. There were
no genotype differences in either P-Akt or P-ERK, sug-
gesting that in the absence of En2, baseline pathway
activation was similar to WT in developing cerebellum
(Figure 4A).
To determine whether IGF1 signaling through PI3K-
Akt or MAPK is altered specifically in GNPs in the
absence of En2, cells were isolated from each genotype
and cultured at cell densities similar to those used in the
3H-dT proliferation assays. To assess IGF1 activity, KO
and WT GNPs were cultured in defined media for 2 h
without IGF1 and were then pulsed for 30 min with
vehicle or 10 ng/ml IGF1. Both KO and WT GNPs ex-
hibited almost no P-Akt activation in vehicle-treated
control cultures (Figure 4B). Conversely, IGF1 elicited
identical, robust phosphorylation of Akt in both geno-
types. Previous studies show that PI3K pathway activa-
tion, measured by phosphorylation of Akt, occurs within
minutes of growth factor treatment and becomes max-
imal at 1 h [67]. However, our culture results on mitosis
and differentiation were obtained following continuous
growth factor exposure for 24 h. Therefore, experiments
were repeated at several later time points, including
IGF1 treatments of 15 min, 4 h and 8 h. Though IGF1
increased P-Akt early at 15 min, and to a lesser degree
at 4 h and 8 h, there were no differences between the ge-
notypes; further, phospho-GSK3-beta protein levels were
also no different between genotypes (data not shown).
Furthermore, IGF1 pulses did not significantly increase
P-ERK at any time point, nor were P-ERK levels differ-
ent between the genotypes (Figure 4C). This suggests that
in our culture models, IGF1 preferentially activates the
PI3K-Akt pathway, whereas the MAPK pathway is constitu-
tively activated, similar to previous reports [68]. Genotype-
specific differences in IGF1 responses do not appear to be
mediated by these dominant upstream pathways.
Given the dominance of the PI3K pathway in our cul-
ture models, differences in En2 KO and WT GNP re-
sponses to IGF1 were explored further downstream of
Akt. The downstream Akt target, mammalian target of
rapamycin (mTOR), is known to regulate cell cycle pro-
gression as well as protein translation via activation
of S6 kinase (S6K) and eukaryotic initiation factor 4B
(eIF4B) [69]. In contrast to the upstream signals, IGF1
induced a differential genotype response in phospho-S6
kinase (P-S6K), eliciting a 25-fold increase in P-S6K
levels in KO GNPs at 30 min, but inducing no signifi-
cant increase in WT GNPs (Figure 4D). These data sug-
gest that the differential genotype response of WT and
KO GNPs to IGF1 may reflect a previously undefined
interaction between En2 and downstream effector mole-
cules of the IGF1-PI3K-Akt-mTOR signaling cascade.
Figure 4 IGF1 induces greater levels of phospho-S6 kinase in KO GNPs compared to WT cells. (A) Untreated cerebellar lysates from freshly
dissected 7-day-old (P7) WT and KO mice demonstrate identical baseline levels of both P-Akt and P-ERK. (B) The levels of P-Akt protein induced
by a 30-min pulse of IGF1 was quantified in WT and KO GNPs by Western blot with densitometric analysis, and no significant differences were
found between genotypes (C = control; I = IGF1). (C) IGF1 induced robust, but similar increases in P-Akt in both WT and KO GNPs after a 15-min
pulse. This effect was attenuated at 4 h and 8 h, and no activity was found at 24 h (data not shown). P-ERK, on the other hand, appeared
constitutively activated in these culture conditions, with no change in levels in either genotype following IGF1 treatment. (D) Phospho-S6 kinase,
which is downstream of Akt, was markedly upregulated in KO GNPs pulsed 30 min with IGF1 compared to untreated GNPs. In contrast, IGF1 failed
to upregulate phospho-S6 kinase in WT GNPs (though it robustly increased P-Akt), suggesting En2 may be an important negative regulator of the
S6 kinase pathway. Total S6 kinase protein levels were not different between genotypes (not shown). Densitometry quantification in B and D is
expressed in arbitrary units as percent control ± SEM. n = 3 experiments per genotype (3 animals per experiment, per genotype); #, Significance
compared to genotype control, p ≤ 0.05; **, significance compared across genotypes, p ≤ 0.01.
Rossman et al. Molecular Autism 2014, 5:9 Page 10 of 18
http://www.molecularautism.com/content/5/1/9Overexpression of En2 cDNA promotes cell cycle exit
and differentiation
Given our findings that the absence of En2 resulted in in-
creased GNP proliferation and decreased differentiation, it
follows that overexpression should elicit opposite effects:
increased GNP cell cycle exit and differentiation. Previ-
ously, we demonstrated that ectopic En2 overexpression
in embryonic cortical precursors altered neurogenesis [7],
and additional studies in HEK293 cells confirmed that
transfection produces overexpression of En2 cDNA (not
shown). Using these same vectors, we overexpressed En2
by lipid transfection of P7 GNPs.
GNPs were isolated from P7 WT mice and transfected
2 h after plating with the En2-GFP cDNA vector or con-
trol GFP vector. Proliferation was assessed 24 h after the
5-h transfection period by a terminal 4-h pulse of BrdU,
approximately 30 h post plating. While GNPs trans-
fected with control GFP vector exhibited a BrdU LI of
6.54%, overexpression of En2 completely abolished BrdU
labeling (Figure 5A-H; p ≤ 0.05; n = 8 per vector). In
addition to cell cycle withdrawal, En2 overexpression
elicited a 2.5-fold increase in WT GNPs exhibiting neur-
onal morphologies (i.e., neurite-bearing cells, Figure 5I,
K) compared to GFP-transfected controls, indicating
that En2 overexpression promotes cell cycle exit andearly differentiation. Moreover, in GNPs from the KO
mouse, En2 overexpression elicited effects that were nearly
identical to WT cells, demonstrating a two-fold increase
in cells exhibiting neuronal morphologies (Figure 5J,K).
These data suggest the deficits in neurite outgrowth
observed in KO GNPs (Figure 3) that are due to the devel-
opmental absence of En2 were rescued by acute re-
expression of the transcription factor at P7. Thus, as
predicted, En2 overexpression produced effects opposite to
En2 deletion, reducing markers of proliferation while in-
creasing markers of differentiation.
To further explore En2 effects, we performed additional
studies in postnatal rats, which exhibit very similar cere-
bellar development [70,71], because several antibodies
were ineffective for murine cells, and postnatal rats were
more readily available. En2 DNA and protein sequences
are highly homologous across mammalian species,
with ~96% homology between mouse and rat [72]. As
observed in mouse, rat GNPs overexpressing En2 also
exhibited a reduction in BrdU LI, by 67%, compared to
GFP-only transfected cells (Figure 6A). However, changes
in BrdU labeling may possibly reflect changes in cell cycle
stage lengths. To more directly assess precursor status, we
immunostained GNPs for proliferating cell nuclear anti-
gen (PCNA). In contrast to BrdU, PCNA is expressed
Figure 5 Overexpression of En2 cDNA decreases mitotic labeling and increases neurite outgrowth of P7 mouse GNPs. P7 mouse GNPs
were transfected for 5 h with GFP control or En2-GFP cDNA vectors and 24 h later following BrdU treatment were fixed and immunostained for
BrdU. Transfection efficiency was approximately 10% for each vector, with similar total numbers of transfected cells. Cells are shown (400×) under
phase (A, E) or fluorescence (B-D; F-H) microscopy, after transfection with GFP control vector (A-D) and En2-GFP vector (E-H), revealing GFP
(green; B, F), BrdU (red; C, G) and double labeling (D, H). Arrows point to double-labeled cells in A-D, whereas arrowheads in E-H identify cells
that express GFP only, separate from cells with BrdU signal. (I) Examples of GNPs from WT mice transfected with GFP control and En2-GFP vectors
that extend neurites >2 cell somas exhibiting a range in size. (J) Examples of GNPs from KO mice transfected with GFP and En2-GFP vectors that
extend neurites >2 cell somas. (K) En2 overexpression increased the proportion of GNPs exhibiting neuronal morphologies by 2.5-fold in WT cells
as well as by two-fold in KO cells. n = 6-15, each vector, 3–5 experiments; *, significance between GFP and En2, p ≤ 0.05; **, p ≤ 0.01.
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it a more sensitive marker of the precursor cell compart-
ment [73]. More than 30% of GNP exhibited PCNA
immunoreactivity (Figure 6B), suggesting that many
cells were proliferative precursors. Overexpression of En2reduced PCNA immunostaining by 52% (Figure 6B), sug-
gesting that gene overexpression induced cells to transi-
tion from precursors to postmitotic neurons. Additionally,
similar to mouse GNPs, overexpression of En2 in rat
GNPs resulted in a two-fold increase in cells exhibiting
Figure 6 En2 cDNA overexpression in P7 rat GNPs also elicits reduced proliferation and increased neurite outgrowth. (A) Following
En2 overexpression, the BrdU LI of rat GNP at ~30 h was reduced by 67%. (B) PCNA expression was reduced 52% in P7 rat GNPs following En2
overexpression; n = 6 each vector. Data are expressed as percent PCNA + GFP+/total GFP + cells. N = 6-12 for each vector, 3 experiments.
*,p ≤ 0.05. (C) Overexpression of En2 in rat GNPs doubled the proportion of cells with neuronal morphologies, replicating results observed in
mouse. (D) Overexpression of En2 in rat GNPs increased the proportion of Map1b + cells among all GFP + cells, including neurite-bearing and
non-neurite-bearing cells, suggesting En2 may serve to promote differentiation prior to the onset of neurite outgrowth. n = 6-15, each vector,
3–5 experiments; *, significance between GFP and En2, p ≤ 0.05.
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bearing cells characteristically express cytoskeletal proteins
such as microtubule-associated protein 1b (Map1b), which
is a known target for regulation by En [74]. En2 overex-
pression increased Map1b immunostaining in transfected
GNPs by 27% (Figure 6D). Together, these data suggest
En2 overexpression promotes rat GNP cell cycle exit simi-
lar to mice, suggesting En2 may have an evolutionarily
conserved function in other mammalian species.
Discussion
Based on both loss- and gain-of-function approaches,
our studies suggest En2 promotes GNP cell cycle exit
and differentiation during postnatal cerebellar develop-
ment. In the absence of En2, GNPs displayed increased
proliferation markers in vivo and in culture. Further,GNPs elaborated fewer neuronal processes in response
to growth factors but exhibited no differences in sur-
vival. Conversely, overexpression of En2 promoted cell
cycle exit and stimulated neurite outgrowth, an effect
demonstrated in both mouse and rat GNPs. Finally, we
identified previously unknown interactions of En2 with
IGF1 signaling. In the absence of En2, IGF1 elicited
greater stimulation of DNA synthesis in culture and
in vivo, effects associated with marked activation of
phospho-S6K, while there were no changes in upstream
PI3K and ERK signaling. Significantly, regulation of pro-
liferation by other mitogenic signals was unaffected.
These studies characterize En2’s roles in postnatal cere-
bellar GNP neurogenesis and differentiation and interac-
tions with IGF1, which invite further study with respect
to the role of En2 in the pathogenesis of development
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ASD and schizophrenia.
En2 promotes cell cycle exit
During postnatal cerebellar development, outer EGL
GNPs proliferate robustly, producing a large population
of internal granule layer neurons. Underlying Purkinje
neurons regulate this process by producing extracellu-
lar growth factors, including Shh, IGF1 and PACAP
[49,50,75]. However, cell intrinsic mechanisms also regu-
late the GNP transition from proliferation to post-
mitotic differentiation [76]. While mechanisms remain
undefined, we present evidence suggesting En2 serves to
promote GNP cell cycle exit. These findings parallel evi-
dence that outer EGL GNPs that are devoid of En2
remain proliferative while inner EGL GNPs begin ex-
pressing En2 as they exit the cycle [15,24]. Indeed, when
isolated in culture, GNPs from the WT mouse were less
proliferative than those from the KO. These observations
suggest En2 normally inhibits cell cycle progression in a
cell-autonomous fashion, a model that is also supported
by En2 overexpression that reduces S phase entry and
precursor PCNA expression.
En2 modulates IGF1 signaling
Purkinje neurons secrete growth factors, such as Shh,
FGF, IGF1, BDNF and PACAP, that support local GNP pro-
liferation, survival and differentiation [37,46,49,52,65,77-79].
We find En2 expression modulates GNP responses to IGF1,
suggesting that the onset of En2 expression contributes to cell
cycle exit and differentiation in the growth factor-rich environ-
ment of the EGL. In En2 KO GNPs, IGF1 induced two- to
three-fold greater increases in DNA synthesis in culture and
three-fold greater stimulation of cerebellar DNA synthesis
in vivo. Importantly, En2 did not appear to regulate overall cell
cycle machinery or signaling by other growth factors that em-
ploy signaling systems similar to IGF1, such as tyrosine-kinase
engaging receptors or PI3K/Akt or MAPK pathways. Rather,
in the absence of En2, IGF1 markedly upregulated P-S6K,
an effect not observed in WT cells. While P-S6K is a well-
defined regulator of mitogen-induced cell cycle progression
[69], there were no genotype differences in upstream PI3K-
Akt-GSK3beta or MEK/ERK pathways. To our knowledge,
this is the first report of interactions between En2 expression
and IGF1 signaling.
These initial observations require further study to (1)
define relationships of P-S6K activation to enhanced
mitogenesis and (2) identify mediating upstream regula-
tors, potentially members of the mTOR complex 1 fam-
ily [69,80,81]. Indeed, extracellular mitogens promote
mTOR signaling, which acts through S6K and eIF4B
to promote cell proliferation [80]. eIF4B phosphoryla-
tion by S6K in turn is growth-factor dependent and im-
portant for promoting ribosome-mRNA binding, andconsequent growth and proliferation [69]. Significantly,
Engrailed 2 protein has previously been shown to bind
eIF4E [82]. Thus, Engrailed 2 may interact with other
members of the eIF4 family, such as eIF4B, providing
a mechanism through which En2 alters downstream
mTOR signaling. This might explain the increases in
IGF1-induced proliferation we observe both in vitro and
in vivo. However, what underlies the increased IGF1-
induced S6K phosphorylation in En2 KO cells? Inde-
pendent of Akt-mTOR signaling, IGF1 activates through
PI3K the 3-phosphoinositide-dependent protein kinase 1
(PDK1), which is known to phosphorylate S6K (Figure 7)
[83]. Thus, PDK1 is a candidate in addition to mTOR
for further study. Furthermore, since S6K itself nega-
tively regulates IGF1 signaling by phosphorylating the
insulin response substrate 1 (IRS1) [84], En2 may disrupt
this inhibitory feedback loop, leading to increased S6K
phosphorylation and activation via mTOR-dependent
and -independent pathways downstream of PI3K. Thus,
our data suggest En2 may function normally to attenuate
mTOR-mediated proliferation in a growth factor-rich
environment, though the mechanisms by which this may
occur remain to be explored.
In addition to altered mitogenesis, En2 KO GNPs
grew fewer neurites in response to neuritogenic factors,
IGF1 and PACAP, though their combination synergistically
overcame differentiation deficits. Decreased IGF1-induced
neuritogenesis was not merely due to failed cell cycle exit,
a possibility because the PACAP rescue of reduced neurite
outgrowth was accompanied by inhibition of proliferation
[38]. Rather, treatment with another anti-mitogen, FGF2,
did not rescue the differentiation defect, but in fact attenu-
ated IGF1-stimulated neuritogenesis in both genotypes.
Significantly, GNP survival was also not compromised in
the absence of En2, nor was growth factor-induced troph-
ism. In aggregate, these data suggest that a complex array
of mitogenic, trophic and differentiative signals within the
EGL act in concert with cell-autonomous gene expression
(i.e., En2 expression) to execute GNP maturation.
Previous evidence indicates that multiple interactions
of intrinsic and extrinsic signals control GNP prolifera-
tion. With regard to extrinsic signals, we previously
found that PACAP inhibits Shh-induced GNP mitosis by
upregulating adenylate cyclase [38], whereas others show
similar roles for bone morphogenetic proteins via Smad
[53,85]. Conversely, in the current study, we find IGF1
and Shh synergistically stimulate DNA synthesis. Fur-
thermore, interactions between intrinsic signals and
growth factors are also known. For example, transcrip-
tion factor Atoh1/MATH1 expressed in EGL precursors
promotes Shh-induced proliferation [86] by regulating
expression of downstream target, Gli1 [87]. Similar
promitogenic effects have been defined for Zic family
members, including 1, 2 and 4, as well as ATF5 [88-90].
Figure 7 En2 modulates IGF1’s pleiotropic effects in GNPs, potentially through altered S6 kinase activation. While En2 expression
appeared to have no effect on IGF1 activation of the PI3K pathway at the level of Akt phosphorylation, the absence of En2 caused increased
phosphorylation of S6 kinase. Thus, we propose a model in which En2 expression in postnatal GNPs promotes differentiation and inhibits
proliferation via disruption of S6 kinase activation, a well-characterized promitogenic signal. Potential targets for En2 may include PDK1 and
mTORC1, which directly phosphorylate S6K, though these interactions remain to be explored. Alternatively, En2 may alter feedback inhibition
between the S6K and the PI3K pathway. Dashed lines signify indirect pathways. Arrows and (+) indicate activation. Flat head and (−) indicate
inhibition. GNP = Granule neuron precursor. IGF1R = Insulin-like growth factor-1 receptor. P = Phosphorylation.
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exit the cell cycle, and overexpression inhibits proliferation
[91,92], findings that parallel our observations with En2.
Thus, a number of gene-growth factor interactions likely
contribute to GNP development. That no other mitogenic
or anti-mitogenic signal elicited genotypic differences in
En2 KO and WT GNPs suggests there is a specific yet
indirect interaction between En2 and IGF1 signaling
(Figure 7), with one feature being altered S6K activation.
The expression of En2 by GNPs may facilitate their transi-
tion from proliferation to differentiation in an environment
rich in mitogenic signals [93], thereby allowing subpopula-
tions of cells to continue cycling while others exit and differ-
entiate. En2 expression has been reported to be greater in
the vermis than the hemispheres [15,24], which may be one
mechanism explaining the delay between vermis and hemi-
sphere GNP proliferation during development [23].
En2 overexpression promotes cell cycle exit and
differentiation
Previously, we found that ectopic En2 overexpression in
embryonic cortical precursors increased proliferation [7].This stimulatory effect, opposite to what we observe
here, is consistent with the universal expression of
En2 in prenatal hindbrain progenitors and suggests
that before birth En2 serves to maintain proliferation.
In the current study of postnatal GNPs, En2 overex-
pression completely abolished BrdU labeling in WT
mouse cells and reduced markers of proliferation
(PCNA and BrdU) in rat GNPs. Additionally, En2
overexpression more than doubled the proportion of
mouse and rat GNPs that exhibited neurite out-
growth. Significantly, neurite outgrowth was stimu-
lated even in KO GNPs, suggesting that acute En2
expression may reverse morphological deficits associ-
ated with the absence of En2 for all of development,
though additional studies are warranted. Furthermore,
despite biological differences in GNPs from mice and rats
[38], En2 overexpression produced similar phenotypes in
both species, suggesting En2 function is evolutionarily
conserved. The opposite consequences of En2 deletion
and overexpression on GNP maturation suggest En2 pro-
motes cell cycle exit and differentiation during postnatal
cerebellar development.
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the unexplored role of En2 in prenatal cerebellar neuro-
genesis. While postnatal granule neurogenesis ultimately
dictates final cerebellar morphology and size, prenatal
patterning events organize the developing cerebellum
and delineate neuronal progenitor cell populations, ul-
timately producing a cytoarchitectural framework for
future axonal pathway elaboration [15,94-97]. In the
early cerebellar anlagen, En2 expression is ubiquitous, as
is progenitor cell proliferation; therefore, En2 is unlikely
to promote cell cycle exit and differentiation at this
time. Previous studies suggest En2 may function during
this period to specify numbers as well as types of
progenitor cells that will give rise to various cerebellar
neuronal populations [14,16,50,95,96,98]. Thus, our cha-
racterization of postnatal En2 function is likely a time-
locked developmental phenomenon that cannot address
its prenatal activities. Rather, our demonstration of in-
creased GNP proliferation may potentially suggest why
En2 KO mice are capable of producing cerebella at all,
despite the prenatal insult.
EN2 and ASD
We reported previously that intronic polymorphisms
(A-C haplotype) of human EN2 are associated with ASD
[7,9] and that the presence of these SNPs results in
altered transcription factor binding as well as increased
levels of gene expression [99]. Furthermore, our recent
studies indicate that in human cerebellum, the disease-
associated allele produces increased EN2 expression
[100]. If the En2 activity defined here in rodent studies
is relevant to primates, how then would altered EN2 ex-
pression be expected to affect humans? Increased EN2
expression during postnatal cerebellar development, the
period when the majority of human granule neurons are
generated, would likely produce a granule neuron deficit
by eliciting premature cell cycle exit. However, as with
the mice, such a simple prediction is unwarranted be-
cause the prenatal effects of gene alteration remain un-
defined. But at the broader level, children with ASD
exhibit a range of cerebellar structural abnormalities,
including a diminished vermis as well as enlarged
hemispheres in which granule neuron numbers are dys-
regulated [3,101-103], a phenotype to which EN2 may
contribute. Indeed, in mouse models, both gene deletion
as well as ectopic overexpression produces cerebellar
hypoplasia [13,18,20]. In addition, cerebellar abnormal-
ities have been described in human and mouse studies
of autistic phenotypes in tuberous sclerosis as well as a
number of neuropsychiatric disorders including schizo-
phrenia, attention deficit hyperactivity disorder, and cog-
nitive and language disabilities [35,104-106].
Another interesting implication of our studies is iden-
tification of an interaction between En2 expression andIGF1, the latter being an important pleiotropic growth
factor associated with disease as well as a possible thera-
peutic target. Riikonen et al. [107] reported reduced
IGF1 in cerebrospinal fluid (CSF) of ASD children com-
pared to age-matched controls and that CSF levels cor-
related with head circumference in ASD, but not control
children. Given the En2-IGF1 interaction we describe, one
might speculate whether altered EN2 expression may co-
incide with abnormal IGF1 to contribute to ASD patho-
genesis, a question that remains to be investigated. From a
therapeutic perspective, the Akt-mTOR-S6K pathway is
dysregulated in multiple animal models of monogenic
causes of ASD including fragile X mental retardation
[108], Rett syndrome [109] and tuberous sclerosis [110],
whereas IGF1 ligands may improve neurodevelopmental
symptoms in Rett [111] and the SHANK3 autism-related
mouse model of Phelan-McDermid syndrome [112]. It is
intriguing that yet another autism-associated gene, in this
case EN2, implicates disordered Akt-mTOR-S6K signaling
in the disease phenotype [113]. The exact molecular
mechanisms mediating En2’s modulation of IGF1 signal-
ing remain to be elucidated.
Conclusions
Our current studies aimed to define the function of one
autism-associated gene, EN2, at a specific time during
postnatal brain development. Using both a loss of func-
tion KO mouse and a gain of function cDNA overex-
pression vector, we demonstrated that En2 promotes
postnatal cerebellar GNP cell cycle exit and differenti-
ation. Further, we characterized a previously unknown
interaction between En2 and an important developmen-
tal growth factor, IGF1, and demonstrated downstream
signaling pathway activation through S6K, a target of the
mTOR pathway. These data add to the understanding of
postnatal cerebellar development and the complex gene-
growth factor interactions that regulate cell biologic pro-
cesses such as proliferation and differentiation. Further,
they provide insight into a possible pathogenetic mechan-
ism by which ASD-associated alleles in human EN2 may
alter neurodevelopment during a critical period in suscep-
tible patients. While further investigation remains to de-
fine the mediators of the phenomena described here, these
observations add further support to a previously recog-
nized signaling pathway as a potential target for therapy.
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